get a key
steadybase-$ company TNXP
account_id none on file
legal_name Tonix Pharmaceuticals Holding Corp.
ticker TNXP
cik 1430306
domain tonixpharma.com
entry_point_account_id none on file
exchange Nasdaq
sector Health Care
hq Berkeley Heights, NJ, United States
calls 0 filings 68 executives 7 family 0
why_nownone on file
callsnone on file
filings
due to increased clinical expenses of $1.3 million and manufacturing expenses of $4.5 million as a result of advancing our prioritized pipeline period over period, as well as increased employee-related costs of $2.5 million due to increased headcount.

filing / Aug 10, 2026 / receipt

Consumer sales discounts represent programs the Company has in place to reduce costs to the patient. This includes copay

filing / Aug 10, 2026 / receipt

result increased headcount. The table below summarizes our direct research and development expenses for our product candidates and development platform for the six months ended June 30, 2026, and 2025.

filing / Aug 10, 2026 / receipt

million collateralizes a letter of credit issued in connection with the lease of office space in Berkeley Heights, New Jersey.

filing / Aug 10, 2026 / receipt

$ 2.2 million collateralizes a letter of credit issued in connection with the lease of office space in Berkeley Heights, New Jersey

filing / Aug 10, 2026 / receipt

million collateralizes a letter of credit issued in connection with the lease of office space in Berkeley Heights, New Jersey and

filing / May 11, 2026 / receipt

million, collateralizes a letter of credit issued in connection with the lease of office space in Chatham, New Jersey and New York,

filing / May 11, 2026 / receipt

sales discounts represent programs the Company has in place to reduce costs to the patient. This includes copay buy down and eVoucher

filing / May 11, 2026 / receipt

Tonix Medicines’ Commercial Team has ~100 Years of Commercial and Launch Expertise

ir_statement / Sep 17, 2026 / receipt

Reduces internal spend

ir_statement / Sep 17, 2026 / receipt

Sales Force1 ~90 Reps Initially

ir_statement / Sep 17, 2026 / receipt

Tonix has engaged Inizio, a leading contract sales organization, to provide the majority of its sales force.

ir_statement / Sep 17, 2026 / receipt

executives
Carolyn E. Taylor director - receipt
James Treco director - receipt
Jessica Morris Chief Operating Officer - receipt
Margaret Smith Bell director - receipt
Newcomb Stillwell director - receipt
Richard Bagger director - receipt
Siobhan Fogarty Chief Technology Officer - receipt
familynone on file
upcoming
2026-11-09 earnings call scheduled webcast / ir
changes
2025-02-04 Chief Technology Officer, appointed sec_8k
2023-02-23 director, appointed sec_8k
2021-07-19 director, appointed sec_8k
2020-06-10 director, appointed sec_8k
2019-02-20 director, appointed sec_8k
2018-01-09 Chief Operating Officer, appointed sec_8k
2018-01-09 Chief Operating Officer, appointed sec_8k
2017-09-14 director, appointed sec_8k
mcp_package_hint
steadybase-$